Yahoo Finance Site Map
ArticlesFor a comprehensive guide to our content, please see the Site Index
SiteMap 2023 > 12 > 12
Other dates of the month:
- 10 Money-Saving Tax Moves You Can Still Make Before 2023 Ends
- 3 Cathie Wood Stocks to Sell Before It’s Too Late
- NextEra Energy Transmission MidAtlantic transmission proposal selected by PJM
- UPDATE 2-Japan Nov wholesale inflation slows sharply as cost pressures ease
- Feds for Freedom Announces, Federal Vaccine Mandate Challenge to Continue as Supreme Court Rules on Procedural Grounds
- Those who invested in Chin Teck Plantations Berhad (KLSE:CHINTEK) five years ago are up 37%
- Akanda Corporation Announces CFO Appointment
- AccountAbility Joins with Global Commons Alliance and UN Climate Champions Team to Launch Navigator Addressing Nature and Climate Action
- How rising prices for restaurants, car repair and other services kept inflation up last month
- Netflix back up for most U.S. users as technical issues causing outage resolved
- Alexander & Baldwin Fourth Quarter 2023 Dividend Authorized
- Harvard Alumni Association ‘unanimously and unequivocally’ supports Claudine Gay
- As Zelensky Visits, Congress Could Decide ‘the Future of the World’
- CORRECTING and REPLACING Edgio Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
- Diversified Royalty Corp. Announces Developments at Sutton Group Realty and Oxford Learning Centres
- Global Laser Protective Eyewear Business Report 2023: Market to Reach $517.5 Million by 2030 - Advanced Filters to Solve Vexing Problems of Traditional Laser Protective Eyewear
- Small business receives inaugural Market award
- Sports Illustrated publisher fires CEO after AI debacle
- 3 Dow Stocks That Are About to Get Absolutely Crushed
- Mullen Group Ltd. 2023 Update and 2024 Business Plan
- Boeing deepens strategy cuts as operations take center-stage -sources
- Republic Services acquires Wallace Bros. Disposal
- UPDATE 2-US judge upholds Texas TikTok ban on state-owned devices
- Adams admin sticking with for-profit $565M migrant shelter contracts amid NYC budget crisis
- Thompson Thrift to Develop Luxury 380-Unit Multifamily Community in Central Florida
- A 'severe recession' may be coming in 2024 as the stock market, job market flash warning signs, strategist says
- Boeing promotes insider to chief operating officer, putting her in the discussion about the next CEO
- Secondhand Goods Demand in Asia Pacific to Surge at 9.7% CAGR through 2034 Amid Sustainability Concerns and Rising Middle-class Population | Future Market Insights, Inc.
- CSL Behring's HEMGENIX® (etranacogene dezaparvovec-drlb) Demonstrates at Three Years Post-Treatment Long-Term Durability, Safety and Greater Bleed Protection Versus Prophylactic Treatment in People Living with Hemophilia B
- Treatment with CARVYKTI® (ciltacabtagene autoleucel) Resulted in Clinically Meaningful Improvements in Health-Related Quality of Life and Reductions in Disease-Specific Symptoms in Patients with Earlier-Line Multiple Myeloma
- Updated Data from the BRUIN Phase 1/2 Study of Pirtobrutinib in Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Presented at the 2023 ASH Annual Meeting
- BMTC GROUP INC. ANNOUNCES FINANCIAL RESULTS FOR THE NINE MONTH PERIOD ENDED OCTOBER 31st, 2023
- Gracell Biotechnologies Presents Updated Clinical Data from FasTCAR-T GC012F Demonstrating Deep and Durable Responses in Newly Diagnosed Multiple Myeloma at ASH 2023
- These Top Nine Human Capital Management Software Providers Will Streamline HR Initiatives This Year, SoftwareReviews Users Say
- US Kidney Cancer Therapeutics and Diagnostics Market to 2028, Featuring Profiles of Amgen, Hoffman-La Roche, Bayer, Pfizer, Bristol Myers Squibb and Novartis
- New Analyses Presented at ASH 2023 Support the Potential Long-Term Response and Safety of Kite’s Tecartus® in Patients With Aggressive Blood Cancers
- Positive Results from Pivotal Trials of CASGEVY™ (exagamglogene autotemcel) Highlighted in Oral Presentations at the American Society of Hematology (ASH) Annual Meeting and Exposition
- Patient-Reported Outcomes from the CARTITUDE-4 Study Showed Clinically Meaningful Improvements in Health-Related Quality of Life and Reductions in Multiple Myeloma Symptoms Following Treatment with CARVYKTI® (ciltacabtagene autoleucel)
- Abecma Delivers Sustained Progression-Free Survival Versus Standard Regimens in Earlier Lines of Therapy for Relapsed and Refractory Multiple Myeloma Based on Longer-Term Follow-up from KarMMa-3
- STAG Industrial REIT (NYSE:STAG): Should You Buy Before Its Upcoming Dividend Hike?
- PRESS DIGEST-British Business - Dec 12
- Gold steadies below $2,000 before CPI data, Fed meeting
- You Would Fire “God” as Your Portfolio Manager
- Fourth Power raises $19M to scale new thermal battery technology using liquid tin
- Australia business mood darkens as activity slows -survey
- Sunnova Reiterates Commitment to Project Hestia, Ethical Business Practices, and Customer Service
- ETF Fund Flows as of December 11, 2023
- Ho-Ho-Hold These 3 Stocks for a Merry Santa Claus Rally
- UPDATE 2-Netflix back up for most U.S. users as technical issues causing outage resolved
- There's Been No Shortage Of Growth Recently For Kretam Holdings Berhad's (KLSE:KRETAM) Returns On Capital